Cite
HARVARD Citation
Chen, T. et al. (2022). Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention. Bioengineered. 13 (4), pp. 8266-8276. [Online].